MiMedx Group (MDXG) to Release Earnings on Wednesday

MiMedx Group (NASDAQ:MDXG) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $89.42 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

MiMedx Group Price Performance

MDXG stock opened at $7.98 on Monday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. The firm has a 50 day moving average price of $8.84 and a 200-day moving average price of $7.66. MiMedx Group has a 52-week low of $5.47 and a 52-week high of $10.14. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of 14.51 and a beta of 1.94.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.